To this end, the Agency, acting particularly through its committees, shall undertake the following tasks:[...](d) ensuring the dissemination of information on adverse reactions to medicinal products authorised in the Community, by means of a database permanently accessible to all Member States; health-care professionals, marketing authorisation holders and the public shall have appropriate levels